19 / 74 · 1:04 · Original AXON film
GHRP-6
The burned-in captions and transcript carry the scientific claims and their limitations. The visuals are conceptual illustrations, not validated molecular models or experimental images. The video has no voice or audio. The full explanation is visible on screen; optional accessible captions are available in the player.
Read every result in its study context. A cell experiment, animal model, exploratory analysis and controlled human trial answer different questions.
Prepared 05 November 2026. Regulatory status is jurisdiction- and date-specific. No claim of specialist review or exhaustive evidence coverage.
Transcript
Ghrelin-receptor signaling
GHRP-6 is a synthetic peptide that acts through the ghrelin-receptor system. That system connects signals about energy balance with growth-hormone release. [1] [2]
Human endocrine experiments
Small human experiments have measured growth-hormone responses. Some also measured ACTH and cortisol, reminding us that changing a signaling pathway can affect more than one hormone. [1]
Appetite experiment: rats
The appetite story needs its own evidence label. A study showing more food intake after GHRP-6 was conducted in rats. That does not quantify the response in people. [2]
Biomarker change ≠ clinical benefit
A short-term hormone change does not establish better recovery, healthy aging, or lasting muscle benefit. FDA flags safety concerns, including glucose and cortisol effects. [3]
Sources and context
These linked sources support the evidence distinctions in this short overview. This is not a systematic review, endorsement or treatment recommendation.
- GHRP-6 stimulates sleep, GH, ACTH and cortisol release in normal man (1995) →Acute endocrine responses, not long-term performance efficacy.
- Glucocorticoid-dependent stimulation of adiposity and appetite by a ghrelin mimetic in the rat →GHRP-6 feeding findings in rats.
- FDA peptide safety information: GHRP-6 →Glucose/cortisol concerns; limited safety information.
